slenyto
rad neurim pharmaceuticals eec sarl - melatonin - sleep initiation and maintenance disorders; autistic disorder - psycholeptics - slenyto is indicated for the treatment of insomnia in children and adolescents aged 2-18 with autism spectrum disorder (asd) and / or smith-magenis syndrome, where sleep hygiene measures have been insufficient.
parlodel tablets 2.5mg
meditpharma ltd 71, triq karmenu camilleri, qormi qrm 4631, malta - bromocriptine - tablet - bromocriptine 2.5 mg - anti-parkinson drugs
circadin 2mg modified-release tablets
flynn pharma ltd - melatonin - modified-release tablet - 2mg
novolizer salbutamol 100mcg microgram powder for inhalation
meda health sales ireland limited - salbutamol - powder for inhalation - 100mcg microgram - selective beta-2-adrenoreceptor agonists
novolizer salbutamol 100 micrograms/dose inhalation powder
mylan ire healthcare limited - salbutamol - powder for inhalation - 100 microgram(s) - selective beta-2-adrenoreceptor agonists; salbutamol
azelastine 0.5 mg/ml eye drops solution
meda health sales ireland limited - azelastine hydrochloride - eye drops solution - 0.5 mg/ml - other antiallergics
optilast 0.5 micromol eye drops solution
meda health sales ireland limited - azelastine hydrochloride - eye drops solution - 0.5 micromol - other antiallergics
optilast 0.05% eye drops
viatris uk healthcare ltd - azelastine hydrochloride - eye drops - 500microgram/1ml
azelastine eye drops, 0.5 mg/ml, eye drops, solution
mylan ire healthcare limited - azelastine hydrochloride - eye drops, solution - 0.5 milligram(s)/millilitre - other antiallergics; azelastine
optilast, 0.5 mg/ml eye drops, solution
mylan ire healthcare limited - azelastine hydrochloride - eye drops, solution - 0.5 milligram(s)/millilitre - other antiallergics; azelastine